Viorgon 19

Bioregulator of liver tissue.

Composition: 1 ml of sterile solution contains; 0.1±0.01 mg of CaCI₂ and 10 ^-10-10^-11 mg of protein-peptide complex.

Recommendations for use: for the prevention of fatty dystrophy, cirrhosis of the liver, with neoplasms.

Method of application: for 20-30 minutes before eating, 10-15 drops of the solution should be dropped under the tongue, washed down with a small amount of water. Take 3-5 times a day. The course of admission is 1-2 months.  Viorgon 19 is combined with the use of other drugs, including medicinal ones.

Contraindications: not detected. Overdose: is excluded. The effect of habituation: is missing.

Storage conditions: in a clean, dry, sun-protected place at a temperature of +5 to +25 °C and a relative humidity of not more than 75%.

Expiration date: 18 months from the date of manufacture.

Release form: 30 ml bottle (≈600 drops).